ANUH PHARMA
Quarterly Results Analysis [Mar2026]
ANUH PHARMA Quarterly Results
| Standalone | Mar2026 UnAudited |
Dec2025 UnAudited |
Sep2025 UnAudited |
Jun2025 UnAudited |
Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
|---|---|---|---|---|---|---|---|---|
| Revenues | ₹202 Cr | ₹197 Cr | ₹186 Cr | ₹186 Cr | ₹198 Cr | ₹160 Cr | ₹166 Cr | ₹138 Cr |
| Expenses | ₹182 Cr | ₹180 Cr | ₹174 Cr | ₹176 Cr | ₹179 Cr | ₹145 Cr | ₹149 Cr | ₹127 Cr |
| Operating Income | ₹20 Cr | ₹17 Cr | ₹12 Cr | ₹10 Cr | ₹19 Cr | ₹15 Cr | ₹17 Cr | ₹11 Cr |
| Other Income | ₹-1 Cr | ₹4 Cr | ₹1 Cr | ₹3 Cr | ₹1 Cr | ₹1 Cr | ₹3 Cr | ₹4 Cr |
| Interest | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Depreciation | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr |
| Profit Before Tax | ₹16 Cr | ₹18 Cr | ₹10 Cr | ₹11 Cr | ₹17 Cr | ₹13 Cr | ₹18 Cr | ₹12 Cr |
| Profit After Tax | ₹12 Cr | ₹13 Cr | ₹8 Cr | ₹8 Cr | ₹12 Cr | ₹10 Cr | ₹15 Cr | ₹10 Cr |
| EPS | ₹1.17 | ₹1.34 | ₹0.76 | ₹0.83 | ₹1.24 | ₹1.03 | ₹1.50 | ₹0.95 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| ANUH PHARMA | -0.2% | -4% | -29.3% |
| SUN PHARMACEUTICAL INDUSTRIES | -3% | -1.9% | 7.5% |
| DIVIS LABORATORIES | -3.3% | -0.7% | -1.6% |
| TORRENT PHARMACEUTICALS | -3.8% | 2.8% | 36.4% |
| CIPLA | -3% | 3% | -6.1% |
| DR REDDYS LABORATORIES | -4.3% | -2% | 2.5% |
| MANKIND PHARMA | -2% | 4.9% | -7.5% |
| LUPIN | -0.7% | -3.8% | 15.9% |
| ZYDUS LIFESCIENCES | -0.9% | 19.4% | 16.5% |
ANUH PHARMA Quarterly Revenues
| Revenues | |
|---|---|
| Q-o-Q | 2.50 % |
| Y-o-Y | 2.01 % |
| Quarters | Revenues | % Change | |
|---|---|---|---|
| Mar2026 | ₹202 Cr | 2.50 | |
| Dec2025 | ₹197 Cr | 6.08 | |
| Sep2025 | ₹186 Cr | -0.32 | |
| Jun2025 | ₹186 Cr | -5.89 | |
| Mar2025 | ₹198 Cr | 24.22 | |
| Dec2024 | ₹160 Cr | -3.88 | |
| Sep2024 | ₹166 Cr | 20.34 | |
| Jun2024 | ₹138 Cr | - | |
ANUH PHARMA Quarterly Operating Profit
| Operating Profit | |
|---|---|
| Q-o-Q | 18.34 % |
| Y-o-Y | 6.49 % |
| Quarters | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹20 Cr | 18.34 | |
| Dec2025 | ₹17 Cr | 41.43 | |
| Sep2025 | ₹12 Cr | 15.44 | |
| Jun2025 | ₹10 Cr | -44.89 | |
| Mar2025 | ₹19 Cr | 26.25 | |
| Dec2024 | ₹15 Cr | -12.39 | |
| Sep2024 | ₹17 Cr | 59.73 | |
| Jun2024 | ₹11 Cr | - | |
| Operating Margins | |
|---|---|
| Q-o-Q | 15.49 % |
| Y-o-Y | 4.46 % |
| Quarters | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2026 | 9.84% | 15.49 | |
| Dec2025 | 8.52% | 33.33 | |
| Sep2025 | 6.39% | 15.76 | |
| Jun2025 | 5.52% | -41.40 | |
| Mar2025 | 9.42% | 1.62 | |
| Dec2024 | 9.27% | -8.85 | |
| Sep2024 | 10.17% | 32.77 | |
| Jun2024 | 7.66% | - | |
ANUH PHARMA Quarterly Profit After Tax
| Profit After Tax(PAT) | |
|---|---|
| Q-o-Q | -13.16 % |
| Y-o-Y | -6.21 % |
| Quarters | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹12 Cr | -13.16 | |
| Dec2025 | ₹13 Cr | 76.74 | |
| Sep2025 | ₹8 Cr | -8.31 | |
| Jun2025 | ₹8 Cr | -33.36 | |
| Mar2025 | ₹12 Cr | 20.42 | |
| Dec2024 | ₹10 Cr | -31.24 | |
| Sep2024 | ₹15 Cr | 58.21 | |
| Jun2024 | ₹10 Cr | - | |
| PAT Margins | |
|---|---|
| Q-o-Q | -15.25 % |
| Y-o-Y | -8.11 % |
| Quarters | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2026 | 5.78 % | -15.25 | |
| Dec2025 | 6.82 % | 66.75 | |
| Sep2025 | 4.09 % | -8.09 | |
| Jun2025 | 4.45 % | -29.25 | |
| Mar2025 | 6.29 % | -2.93 | |
| Dec2024 | 6.48 % | -28.48 | |
| Sep2024 | 9.06 % | 31.49 | |
| Jun2024 | 6.89 % | - | |
ANUH PHARMA Quarterly Earnings Per Share (EPS)
| EPS | |
|---|---|
| Q-o-Q | -12.69 % |
| Y-o-Y | -5.65 % |
| Quarters | EPS | % Change | |
|---|---|---|---|
| Mar2026 | ₹1.17 | -12.69 | |
| Dec2025 | ₹1.34 | 76.32 | |
| Sep2025 | ₹0.76 | -8.43 | |
| Jun2025 | ₹0.83 | -33.06 | |
| Mar2025 | ₹1.24 | 20.39 | |
| Dec2024 | ₹1.03 | -31.33 | |
| Sep2024 | ₹1.5 | 57.89 | |
| Jun2024 | ₹0.95 | - | |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD